The summary below is from the full report titled Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy. It is in the 1 April 2003 issue of Annals of Internal Medicine (volume 138, pages 542-549). The authors are T. Berl, L.G. Hunsicker, J.B. Lewis, M.A. Pfeffer, J.G. Porush, J.-L. Rouleau, P.L. Drury, E. Esmatjes, D. Hricik, C.R. Parikh, I. Raz, P. Vanhille, T.B. Wiegmann, B.M. Wolfe, F. Locatelli, S.Z. Goldhaber, and E.J. Lewis, for the Collaborative Study Group.
Effects of Blood Pressure Drugs in Patients with Diabetes and Kidney Disease. Ann Intern Med. 2003;138:I–43. doi: https://doi.org/10.7326/0003-4819-138-7-200304010-00003
Download citation file:
Published: Ann Intern Med. 2003;138(7):I-43.
Cardiology, Coronary Risk Factors, Diabetes, Diabetic Nephropathy, Endocrine and Metabolism.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use